This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Nexeon Medsystems (NXNN) Stock Overview

NXNN fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($203)

Shares are highly illiquid

Latest financial reports are more than a year old

NXNN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Nexeon Medsystems Inc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nexeon Medsystems
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.0001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-99.00%
5 Year Change	-100.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NXNN	US Medical Equipment	US Market
7D	0%	-4.1%	0.9%
1Y	n/a	-18.2%	28.2%

Return vs Industry: Insufficient data to determine how NXNN performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how NXNN performed against the US Market.

Price Volatility

Is NXNN's price volatile compared to industry and market?
NXNN volatility
NXNN Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.2%

Stable Share Price: NXNN has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NXNN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2015	n/a	Will Rosellini	www.nexeonmedsystems.com

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson’s disease in the United States, as well as for Parkinson’s disease, Essential Tremor, and Dystonia in Europe.

Nexeon Medsystems Inc Fundamentals Summary

How do Nexeon Medsystems's earnings and revenue compare to its market cap?
NXNN fundamental statistics
Market cap	US$203.00
Earnings (TTM)	-US$1.65m
Revenue (TTM)	US$9.82m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is NXNN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NXNN income statement (TTM)
Revenue	US$9.82m
Cost of Revenue	US$7.12m
Gross Profit	US$2.71m
Other Expenses	US$4.36m
Earnings	-US$1.65m

Last Reported Earnings

Sep 30, 2018

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did NXNN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/12/12 17:47
End of Day Share Price	2023/09/14 00:00
Earnings	2018/09/30
Annual Earnings	2017/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nexeon Medsystems Inc is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Howard Halpern	Taglich Brothers, Inc.